Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Scott J. Antonia
The Anti-Fibrotic Agent Pirfenidone Synergizes With Cisplatin in Killing Tumor Cells and Cancer-Associated Fibroblasts
BMC Cancer
Cancer Research
Oncology
Genetics
‹
1
2
Related publications
Anti-Fibrotic Effects of Pirfenidone and Rapamycin in Primary IPF Fibroblasts and Human Alveolar Epithelial Cells
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in the Tumor Microenvironment After Radiotherapy
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Pirfenidone Anti-Fibrotic Effects Are Partially Mediated by the Inhibition of MUC1 Bioactivation
Oncotarget
Oncology
The Crosstalk: Tumor-Infiltrating Lymphocytes Rich in Regulatory T Cells Suppressed Cancer-Associated Fibroblasts
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
HIF1-alpha Functions as a Tumor Promoter in Cancer-Associated Fibroblasts, and as a Tumor Suppressor in Breast Cancer Cells
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Targeting Multiple Tyrosine Kinase Receptors With Dovitinib Blocks Invasion and the Interaction Between Tumor Cells and Cancer-Associated Fibroblasts in Breast Cancer
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Cancer-Associated Fibroblasts Correlate With Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer Patients
Journal of Cancer
Oncology
Oxymatrine and Cisplatin Synergistically Enhance Anti-Tumor Immunity of CD8+ T Cells in Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis
